Maureen J Aarts

Maureen J Aarts

UNVERIFIED PROFILE

Are you Maureen J Aarts?   Register this Author

Register author
Maureen J Aarts

Maureen J Aarts

Publications by authors named "Maureen J Aarts"

Are you Maureen J Aarts?   Register this Author

30Publications

1136Reads

21Profile Views

Cancer-related cognitive problems at work: experiences of survivors and professionals.

J Cancer Surviv 2019 Nov 25. Epub 2019 Nov 25.

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-019-00830-5DOI Listing
November 2019

Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.

Eur Urol Oncol 2019 Aug 9. Epub 2019 Aug 9.

Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.07.011DOI Listing
August 2019

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

J Clin Oncol 2018 08 10;36(24):2504-2513. Epub 2018 Jul 10.

Harmke J. Groot, Jan Martijn Kerst, Katarzyna Jóźwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Flora E. van Leeuwen, and Michael Schaapveld, Netherlands Cancer Institute; Alfons J.M. van den Eertwegh, Vrije Universiteit Medical Center; Heinz-Josef Klümpen, Academic Medical Center, Amsterdam; Sjoukje Lubberts, Igle J. de Jong, Alfons C.M. van den Bergh, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen; Ronald de Wit and Luca Incrocci, Erasmus Medical Center Cancer Institute, Rotterdam; Johannes A. Witjes, Radboud University Medical Center, Nijmegen; Gerard Groenewegen, University Medical Center Utrecht Cancer Center, Utrecht; Philip M. Poortmans, Instituut Verbeeten, Tilburg; Hetty A. van den Berg, Catharina Hospital, Eindhoven; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Ben G.L. Vanneste, MAASTRO Clinic; Maureen J. Aarts, Maastricht University Medical Center, Maastricht, the Netherlands; and Philip M. Poortmans, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.4174DOI Listing
August 2018

Epigenetics in renal cell cancer: mechanisms and clinical applications.

Nat Rev Urol 2018 07;15(7):430-451

Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-018-0023-zDOI Listing
July 2018

Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.

Epigenomics 2017 09 14;9(9):1243-1257. Epub 2017 Aug 14.

Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi-2017-0040DOI Listing
September 2017

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.

Oncotarget 2017 Jul;8(28):46557-46564

Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542292PMC
July 2017

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.

Oncotarget 2017 Feb;8(7):11372-11379

Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355271PMC
February 2017

Sunitinib uptake inhibits platelet function in cancer patients.

Eur J Cancer 2016 10 12;66:47-54. Epub 2016 Aug 12.

Cardiovascular Research Institute Maastricht, Department of Biochemistry, Maastricht University, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.07.016DOI Listing
October 2016

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.

Eur J Cancer 2016 Jan 30;52:67-76. Epub 2015 Nov 30.

Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.10.010DOI Listing
January 2016

Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays.

Lab Invest 2015 Jul 13;95(7):833-42. Epub 2015 Apr 13.

1] Division of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands [2] GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands [3] Institute of Pathology, Medical Faculty, RWTH Aachen University Hospital, Aachen, Germany.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/labinvest201553
Publisher Site
http://dx.doi.org/10.1038/labinvest.2015.53DOI Listing
July 2015

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

J Clin Oncol 2013 Dec 29;31(34):4290-6. Epub 2013 Apr 29.

Maureen J. Aarts and Vivianne C.G. Tjan-Heijnen, Maastricht University Medical Center, Maastricht; Frank P. Peters, Orbis Medical Center, Sittard-Geleen; Caroline M. Mandigers, Canisius Wilhelmina Hospital; Hanneke W. van Laarhoven and George F. Borm, Radboud University Nijmegen Medical Center; Saskia M. van Gastel; Comprehensive Cancer Centre East; George F. Borm, Nijmegen I, Nijmegen; M. Wouter Dercksen, Maxima Medical Center, Veldhoven; Laurence J. van Warmerdam, Catharina Hospital, Eindhoven; Jacqueline M. Stouthard, Maasstad Medical Center; Carin C. van der Rijt, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam; Hans J. Nortier, Leiden University Medical Center; Erdogan Batman, Diaconessenhuis Leiden, Leiden; Agnes J. van de Wouw, VieCuri Medical Center, Venlo; Esther M. Jacobs, Elkerliek Hospital, Helmond; Vera Mattijssen, Rijnstate Hospital, Arnhem; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Annette W. van der Velden, Martini Hospital, Groningen; Mehmet Temizkan, Hospital St Jansdal, Harderwijk; and Erik W. Muller, Slingeland Hospital, Doetinchem, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.6229DOI Listing
December 2013

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

J Clin Oncol 2013 Dec 28;31(34):4283-9. Epub 2013 Oct 28.

Maureen J. Aarts, Vivianne C. Tjan-Heijnen, Janneke P. Grutters, Manuela A. Joore, Maastricht University Medical Center, Maastricht; Frank P. Peters, Orbis Medical Centre, Sittard; Caroline M. Mandigers, Canisius Wilhelmina Hospital, Nijmegen; M. Wouter Dercksen, Maxima Medical Center, Veldhoven; Jacqueline M. Stouthard, Maasstad Medical Center, Rotterdam; Hans J. Nortier, Leiden University Medical Center, Leiden; Hanneke W. van Laarhoven, George F. Borm, Radboud University Nijmegen Medical Centre, Nijmegen; Laurence J. van Warmerdam, Catharina Hospital, Eindhoven; Agnes J. van de Wouw, VieCuri Medical Center, Venlo; Esther M. Jacobs, Elkerliek Hospital, Helmond; Vera Mattijssen, Rijnstate Hospital, Arnhem; Carin C. van der Rijt, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam; Tineke J. Smilde, Jeroen Bosch Hospital, 's-Hertogenbosch; Annette W. van der Velden, Martini Hospital, Groningen; Mehmet Temizkan, Hospital St Jansdal, Harderwijk; Erdogan Batman, Diaconessenhuis Leiden, Leiden; Erik W. Muller, Slingeland Hospital, Doetinchem; Saskia M. van Gastel, Comprehensive Cancer Center East, Nijmegen the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.3644DOI Listing
December 2013

Bishop score and risk of cesarean delivery after induction of labor in nulliparous women.

Obstet Gynecol 2005 Apr;105(4):690-7

Department of Obstetrics and Gynecology, Atrium Medical Center, Heerlen, VieCuri Medical Center, Venlo, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.AOG.0000152338.76759.38DOI Listing
April 2005